Houston Methodist account plan
leading health system hospitals
At a glance
Houston Methodist is a not-for-profit Houston health system with an academic flagship and seven community hospitals; 2025 revenue was $9,170.2 million.
Houston Methodist is a Texas not-for-profit health system that operates a large academic medical center hospital in the Texas Medical Center, a research institute, physician organizations, seven community hospitals and medical office buildings across the Houston area. Its academic affiliations include Weill Medical College at Cornell University, New York-Presbyterian Hospital and Baylor College of Medicine. In 2025 total revenue was $9,170.2 million (net patient revenue $8,768.5 million), operating income $591.7 million and revenue over expense $1,542.4 million. CEO Marc Boom describes it as an organization of 35,000 employees.
Business units
Academic medical center hospital (flagship)
The flagship academic hospital in the Texas Medical Center carries the system's teaching and research affiliations. Houston Methodist spent about $213.0 million on internally funded research and education in 2025. Roberta Schwartz is CEO of Houston Methodist Hospital.
Research institute
Federal research award expenditures were $70.5 million in 2025, mostly from the Department of Health and Human Services. Donor-restricted net assets for research were $556.3 million.
Community hospitals
Seven community hospitals across greater Houston; the seventh opened in 2025, built as a "hospital of the future" and used as a proving ground. The statements give no figures per hospital.
Physician organizations
A large physician organization that is part of the system; no separate figures are given.
Medical office buildings
$18.5 million of 2025 rental revenueMethodist leases medical office space to physician practices at market rates; the buildings had a carrying value of $730.6 million at December 31, 2025.
Strategic priorities
- Year of maturation for innovation
- 2026 is about scaling the strongest innovations from four years of pilots, under the "10 Bets for the Intelligent Health Care System" roadmap, focusing on what can show ROI on a three-year horizon.
- Ambient AI and Smart Spaces
- An ambient AI pilot was scaled from 36 to more than 200 operating rooms after a 15% increase in surgical volume, and the plan is to extend this into Smart Spaces across the system.
- Virtual care across every room
- Cameras in every room support virtual ICU, virtual nursing, telemonitoring and virtually started rapid response and code teams.
- Affordability
- The CEO calls affordability the biggest question for 2026 and argues that digital innovation has to bend the cost curve.
- Reduce clinician burden
- The second innovation principle is to make clinicians' and employees' lives easier by removing tasks that do not need a person.
Latest results
In 2025 total revenue rose to $9,170.2 million from $8,371.0 million, but operating income fell to $591.7 million from $637.1 million because salaries, supplies and pharmaceuticals grew faster than revenue; EBITDA was flat at $1,134.4 million. Investment results of $950.7 million lifted revenue over expense to $1,542.4 million. Net assets rose to $14,354.1 million and total assets to $19,511.4 million. The statements give no guidance.
Investments and deals
- Capital spending
- Purchases of property and equipment were $1,076.7 million in 2025, with construction in progress of $1,183.1 million at year-end.
- Debt financing
- $1.2 billion of variable-rate bonds issued in 2025, and $1.3 billion of fixed-rate Series 2026A bonds in February 2026 to refund older series.
- New ERP system
- A new Enterprise Resource Management System was implemented on January 1, 2026 as part of a procurement corrective action.
- Community benefit
- An estimated $2,328.1 million of charity care and community benefits in 2025, including $660.4 million of charity care.
Challenges and risks
- Costs growing faster than revenue
- Salaries and related personnel costs reached $4,781.6 million and supplies and pharmaceuticals $1,882.9 million in 2025, lowering operating income.
- Reimbursement risk
- Medicare is 33% of net patient revenue, and the notes warn that changes or funding cuts in Medicare and Medicaid could have an adverse effect.
- Payor concentration
- Two managed care companies account for about 26% of patient receivables.
- Reliance on investment results
- 2025 results relied on $950.7 million of non-operating investment results exposed to market volatility.
What leadership says
“I think digital innovation can bend the cost curve. It has to bend the cost curve,”
“we will succeed fast or we will fail fast.”
“2026 is the year we take the strongest of those innovations, widen their application and help them become more integrated into operations.”
“New technology only succeeds if our clinicians find it to be practical, adoptable and culturally aligned with how they work.”
Where a supplier can help
- Proven AI tools with clear ROI
- The maturation priority favours suppliers whose ambient AI, wearables or virtual care tools can show systemwide impact and ROI within about three years.
- Labour productivity
- Personnel costs growing faster than revenue and the push to cut clinician burden fit workflow automation, documentation and staffing tools.
- Supply and pharmacy cost control
- Supplies and pharmaceuticals costs rising to $1,882.9 million point to supply chain, purchasing and pharmacy optimisation partners.
- Construction and facilities
- Capital spending of $1,076.7 million and large construction in progress create demand for building, equipment and smart-facility suppliers.
- Revenue cycle and payor management
- Reimbursement risk and payor concentration make revenue cycle, contracting and denial-management services relevant.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Houston Methodist?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Houston Methodist - Consolidated Financial Statements, Supplementary Information and Reports Required by the Uniform Guidance, Year Ended December 31, 2025
- Houston Methodist is a Texas not-for-profit system operating a large academic medical center hospital, a research institute, physician organizations, seven community hospitals and medical office buildings in Houston and the surrounding area (Note A).
- FY2025 (year ended December 31, 2025): total revenue $9,170.2 million (2024: $8,371.0 million), of which net patient revenue $8,768.5 million; operating income $591.7 million (2024: $637.1 million); revenue over expense $1,542.4 million after $950.7 million of investment results and other.
- Operating expense rose to $8,035.9 million before depreciation and interest: salaries and related personnel costs $4,781.6 million, supplies and pharmaceuticals $1,882.9 million, services and other $1,371.3 million. EBITDA $1,134.4 million, flat on 2024 ($1,132.3 million).
- Payor mix of net patient revenue: managed care 59%, Medicare 33%, Medicaid 4%, self-pay 1%, other 3%; about 26% of patient receivables were due from two managed care companies.
- Balance sheet at December 31, 2025: total assets $19.5 billion, investments at fair value $10,398.0 million, total net assets $14,354.1 million, cash $658.3 million.
- Heavy capital programme: purchases of property and equipment $1,076.7 million in 2025 (2024: $909.8 million); construction in progress $1,183.1 million; land rose to $501.1 million.
- Debt: issued $1.2 billion of variable-rate Series 2025A-G bonds in 2025 (total bond principal $3,301.8 million); in February 2026 issued $1.3 billion of fixed-rate Series 2026A bonds to refund the 2008A, 2009C and 2020B bonds and part of the 2015 bonds.
- Community commitment: $2.3 billion of charity care and community benefits in 2025 (charity care $660.4 million, up from $455.8 million); about $213.0 million spent on internally funded research and education, including affiliations with Weill Medical College at Cornell University, New York-Presbyterian Hospital and Baylor College of Medicine.
- Clean audit by Ernst & Young LLP (opinion dated March 20, 2026); $70.5 million of federal and $9.2 million of state award expenditures, no current-year findings, low-risk auditee.
- Shaping Health Care for 2026: Insights From the AHA's Incoming Board Chair (AHA Advancing Health podcast, Leadership Dialogue)
- Marc Boom, president and CEO of Houston Methodist for about 14 years and 2026 chair of the American Hospital Association board, reviews 2025 and sets his 2026 priorities.
- Describes Houston Methodist as a flagship academic hospital plus seven network hospitals, an LTAC, a large physician organization and academic enterprise; the seventh network hospital opened in 2025, built "as a hospital of the future" and used as a proving ground.
- Quality: all seven hospitals were in the top group of the Vizient dashboard; the main academic hospital ranked number three out of 118.
- Culture: employee engagement at 97%; Forbes ranked it the number three large employer in the U.S. and number 35 on its innovation list, the highest health system.
- Digital: every room across the system is wired with cameras; virtual ICU, virtual nursing, telemonitoring, telepharmacy, telepsych, telestroke, virtual sitters and virtual hospitalists; rapid response and code teams now start virtually.
- Management maxims: "unparalleled safety, quality, service and innovation", the "and" philosophy, and "don't let the lines cross" (revenue and expense curves).
- Priority for 2026: affordability, working with pharma, supply chain, payers and government; he argues hospitals are "a locus of the cost, but we're not the real reason".
- Believes digital innovation "can bend the cost curve" and that new therapeutics (CAR-T, cellular therapies) must be priced so society can afford them.
- Rethinking Health Care Innovation From the Inside Out (AHA Advancing Health podcast, Leadership Dialogue)
- Marc Boom, president and CEO of Houston Methodist and 2026 AHA board chair, opens the AHA Leadership Dialogue series with Joint Commission COO James Merlino, M.D., on building a culture of innovation.
- Boom's description of Houston Methodist: 35,000 employees, a flagship academic medical center in the Texas Medical Center, seven network hospitals across Greater Houston, an active research institute and GME programmes; he has been there almost 29 years and CEO about 14 years.
- Technologies in use: virtual nursing, ambient listening in the operating rooms, wearable technologies; the internal rule is "we will succeed fast or we will fail fast."
- Two guiding principles for innovation: focus on patients, families and communities first, then make clinicians' and employees' lives easier.
- Boom names affordability "the big A" and the biggest existential question, and says technology may now be on the cusp of bending the cost curve.
- Merlino stresses culture as something leaders can shape, AI guidance rather than regulation from the Joint Commission, and involving clinicians in implementing technology to reduce burden.
- Roberta Schwartz on Why 2026 Is the Year of Maturation for Houston Methodist
- Interview with Roberta Schwartz, chief innovation officer of Houston Methodist and CEO of Houston Methodist Hospital, published on the system's Leading Medicine blog on February 3, 2026.
- Her theme for 2026 is "maturation": after four years of "ideating, piloting and accelerating" on bets for a hospital of the future, 2026 is the year to widen the strongest innovations and integrate them into operations.
- Ambient AI in surgery: a 36-room pilot was scaled to more than 200 operating rooms after early results showed a 15% increase in surgical volume without added staff or space; extended to endoscopy and interventional radiology pilots, "time boost" for open slots and OR tracking boards.
- Next step: turning ambient AI into "Smart Spaces" across the whole system, under a new roadmap called "10 Bets for the Intelligent Health Care System", announced at conferences "last fall" (the article is dated February 2026).
- Investment filter: focus on innovations with systemwide impact that can mature on a three-year horizon; avoid areas not yet ready to add significant ROI.
- The DIOP (digital innovation obsessed people) team mixes operators and IT staff; vendors piloting at Houston Methodist get real-world feedback that matures their products.
- Change management, training and adoption pathways are treated as core to innovation; the goal is for innovations to "feel expected, not experimental".
Questions about Houston Methodist
What is Houston Methodist?
Houston Methodist is a not-for-profit health system in Houston with a flagship academic medical center, seven community hospitals, a research institute, physician organizations and medical office buildings.
What is Houston Methodist's revenue?
Total revenue was $9,170.2 million in 2025, of which $8,768.5 million was net patient revenue, up from $8,371.0 million in 2024.
How many employees does Houston Methodist have?
CEO Marc Boom describes Houston Methodist as an organization of 35,000 employees.
Who leads Houston Methodist?
Marc Boom, M.D., is President and CEO and chairs the American Hospital Association board in 2026. Roberta Schwartz is Chief Innovation Officer and CEO of Houston Methodist Hospital.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)